^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

CYAD-221

i
Other names: CYAD-221
Associations
Trials
Company:
Celyad Oncology
Drug class:
CD19-targeted CAR-T immunotherapy
Related drugs:
Associations
Trials